Does this corelate with the wrong decision for the patient in terms of their condition? I'm sure financially using brand drugs over a genetic, for example, cou

Does this corelate with the wrong decision for the patient in terms of their condition? I'm sure financially using brand drugs over a genetic, for example, could be more costly for the patient but that may not be danger medicially